Search clinical trials for: phosphatidylinositol 3-kinase (PI3K) inhibitor
Total 67537 results
-
PIQUR Therapeutics AGCharite University, Berlin, Germany; University Hospital, Basel, Switzerland; University Hospital Freiburg and other collaboratorsCompletedLymphoma | Non-Hodgkin LymphomaGermany
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
PIQUR Therapeutics AGRoyal Marsden NHS Foundation Trust; University College London Hospitals; Weill... and other collaboratorsCompletedLymphoma, MalignantUnited States, United Kingdom, Serbia, Bosnia and Herzegovina, France, Israel
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
SecuraBioTerminatedLymphoma | Lymphoma, Non-Hodgkin | Follicular Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
GlaxoSmithKlineCompletedActivated PI3K-delta SyndromeUnited Kingdom
-
Novartis PharmaceuticalsCompletedPI3K Pathway Activated TumorsUnited States
-
Kazia Therapeutics LimitedQuotient SciencesCompleted
-
University of California, San FranciscoNovartis Pharmaceuticals; Pediatric Brain Tumor Foundation; The Lilabean Foundation...RecruitingHigh Grade Glioma | Low-grade Glioma | Recurrent World Health Organization (WHO) Grade II GliomaUnited States
-
PIQUR Therapeutics AGM.D. Anderson Cancer Center; Mayo Clinic; University College London Hospitals; Hospital... and other collaboratorsCompleted
-
Rhizen Pharmaceuticals SACompletedLymphoma, B-Cell | T-Cell LymphomaFrance, Italy
-
Genentech, Inc.Completed
-
Anne ChangNovartis PharmaceuticalsTerminatedCarcinoma, Basal Cell | Skin Neoplasms | Basal Cell Nevus Syndrome | Recurrent Skin CancerUnited States
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaTerminatedAutoimmune Hemolytic Anemia | Failure of Two Rounds of TreatmentChina
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaActive, not recruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
Columbia UniversityRecruitingCancer | Insulin Resistance | MTOR Gene Mutation | PI3K Gene Mutation | AKT Gene MutationUnited States
-
SecuraBioCompletedAsthmaGermany, United Kingdom
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Recurrent Non-Hodgkin LymphomaUnited States
-
Rhizen Pharmaceuticals SAWithdrawnPeripheral T Cell LymphomaUnited States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
NRG OncologyNational Cancer Institute (NCI)CompletedEndometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Metastatic Endometrioid AdenocarcinomaUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung Cancer, Solid CancersUnited States, Netherlands
-
University Hospital, RouenFederation Francophone de Cancerologie DigestiveRecruiting
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Zenyaku Kogyo Co., Ltd.Completed
-
UNICANCERTerminated
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Genentech, Inc.Completed
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Zhejiang Cancer HospitalCompletedBreast Cancer | PI3K/AKT/mTOR Pathway Mutation | EverolimusChina
-
Yonsei UniversityCompleted
-
SecuraBioTerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
Anna MartlingSkane University Hospital; Uppsala University HospitalActive, not recruitingColorectal CancerSweden, Denmark, Norway, Finland
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
SecuraBioCompletedA Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
-
SecuraBioCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, United Kingdom, Australia, Germany
-
Zenyaku Kogyo Co., Ltd.Completed
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Novartis PharmaceuticalsCompletedCommon Variable Immunodeficiency (CVID), APDS / PASLIGermany, Russian Federation, Ireland, Italy, United Kingdom, Belarus, Netherlands, Czechia, United States
-
Dana-Farber Cancer InstituteGilead SciencesTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
PfizerTerminatedEndometrial NeoplasmsUnited States, Canada, Spain, United Kingdom, Japan, Russian Federation, Poland, Australia
-
Verastem, Inc.TerminatedLymphoma | Metastatic Cancer | Non Hematologic CancersUnited States, United Kingdom
-
Gilead SciencesCompletedHodgkin LymphomaUnited States
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom